Wesper is transforming obesity and sleep apnea care with advanced home sleep apnea testing (HSAT) and GLP-1 therapy integration. A recent study highlights the impact of BMI, age, and gender on apnea severity, revealing higher risks for men and obese patients. With AI-powered insights and a 95% PSG correlation, Wesper helps providers deliver personalized, effective care for better sleep and metabolic health.

Huxley Medical's SANSA home sleep apnea test now has FDA clearance for cellular data upload, eliminating the need for Bluetooth pairing or apps. This innovation simplifies home testing, improves accuracy, and accelerates diagnoses for sleep physicians. SANSA’s AI-powered, chest-worn patch enhances sleep apnea detection with real-time data transfer. Learn more about this breakthrough in sleep health.

Happy Sleep partners with Dentulu to offer a groundbreaking, at-home sleep apnea diagnosis and treatment solution. The collaboration provides accessible, FDA-approved sleep tests, custom oral appliances, and ongoing care, all covered by most insurance providers. With a focus on convenience and personalized care, this partnership aims to improve sleep health for millions of Americans.

Neurovalens introduces Modius Sleep, an FDA-cleared, non-invasive device designed to treat chronic insomnia. Using safe electrical pulses to stimulate the vestibular nerve, it influences circadian rhythm and sleep patterns, offering a drug-free solution. Available with a physician's prescription, Modius Sleep helps users fall asleep faster and stay asleep longer.